Timothy J. Kropp

552 total citations · 1 hit paper
8 papers, 399 citations indexed

About

Timothy J. Kropp is a scholar working on Pharmacology, Plant Science and Organic Chemistry. According to data from OpenAlex, Timothy J. Kropp has authored 8 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Plant Science and 1 paper in Organic Chemistry. Recurrent topics in Timothy J. Kropp's work include Pesticide Exposure and Toxicity (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Oral microbiology and periodontitis research (1 paper). Timothy J. Kropp is often cited by papers focused on Pesticide Exposure and Toxicity (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Oral microbiology and periodontitis research (1 paper). Timothy J. Kropp collaborates with scholars based in United States and United Kingdom. Timothy J. Kropp's co-authors include Donna A. Volpe, Anne‐Marie Tobin, Thomas Colatsky, R. Daniel Mellon, S. Leigh Verbois, Aspandiar G. Katki, Robert Parker, Rudy J. Richardson, Paul Glynn and Lilliam A. Rosario and has published in prestigious journals such as Biochemistry, Chemical Research in Toxicology and Regulatory Toxicology and Pharmacology.

In The Last Decade

Timothy J. Kropp

8 papers receiving 391 citations

Hit Papers

Uniform assessment and ranking of opioid Mu receptor bind... 2011 2026 2016 2021 2011 100 200 300

Peers

Timothy J. Kropp
Carl E. Wolf United States
Cyrus Rangan United States
Craig D. Logemann United States
Wagdy W. Wahba United States
Joseph R. Monforte United States
Arthur J. McBay United States
Timothy J. Kropp
Citations per year, relative to Timothy J. Kropp Timothy J. Kropp (= 1×) peers Ivan Ricordel

Countries citing papers authored by Timothy J. Kropp

Since Specialization
Citations

This map shows the geographic impact of Timothy J. Kropp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy J. Kropp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy J. Kropp more than expected).

Fields of papers citing papers by Timothy J. Kropp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy J. Kropp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy J. Kropp. The network helps show where Timothy J. Kropp may publish in the future.

Co-authorship network of co-authors of Timothy J. Kropp

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy J. Kropp. A scholar is included among the top collaborators of Timothy J. Kropp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy J. Kropp. Timothy J. Kropp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kropp, Timothy J., et al.. (2013). FDA Engages Collaborators to Address Nonclinical Data Challenges. Therapeutic Innovation & Regulatory Science. 47(1). 41–45. 3 indexed citations
2.
Rosario, Lilliam A., Timothy J. Kropp, Stephen E. Wilson, & Charles K. Cooper. (2012). Join FDA/PhUSE Working Groups to Help Harness the Power of Computational Science. Drug Information Journal. 46(5). 523–524. 2 indexed citations
3.
Volpe, Donna A., Anne‐Marie Tobin, R. Daniel Mellon, et al.. (2011). Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs. Regulatory Toxicology and Pharmacology. 59(3). 385–390. 315 indexed citations breakdown →
4.
Kropp, Timothy J. & Rudy J. Richardson. (2007). Mechanism of Aging of Mipafox-Inhibited Butyrylcholinesterase. Chemical Research in Toxicology. 20(3). 504–510. 11 indexed citations
5.
Kropp, Timothy J. & Rudy J. Richardson. (2006). Aging of Mipafox-Inhibited Human Acetylcholinesterase Proceeds by Displacement of Both Isopropylamine Groups to Yield a Phosphate Adduct. Chemical Research in Toxicology. 19(2). 334–339. 15 indexed citations
6.
Kropp, Timothy J., Paul Glynn, & Rudy J. Richardson. (2004). The Mipafox-Inhibited Catalytic Domain of Human Neuropathy Target Esterase Ages by Reversible Proton Loss. Biochemistry. 43(12). 3716–3722. 27 indexed citations
7.
Kropp, Timothy J. & Rudy J. Richardson. (2003). Relative Inhibitory Potencies of Chlorpyrifos Oxon, Chlorpyrifos Methyl Oxon, and Mipafox for Acetylcholinesterase Versus Neuropathy Target Esterase. Journal of Toxicology and Environmental Health. 66(12). 1145–1157. 23 indexed citations
8.
Chilla, R., Timothy J. Kropp, & C. Arglebe. (1977). [Amylase activity and isoamylase patterns in human parotid saliva (author's transl)].. PubMed. 56(11). 912–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026